Karolinska Institutet, Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska University Hospital, Stockholm, Sweden.
Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.
J Affect Disord. 2018 Oct 1;238:674-679. doi: 10.1016/j.jad.2018.06.030. Epub 2018 Jun 18.
The impact of treatment resistant depression (TRD) on mortality is not established.
Using Swedish national registers, 118,774 patients between 18-69 years of age who had been prescribed an antidepressant and been diagnosed with depression in specialized care were identified. Patients with at least two additional treatment trials during the same depressive episode were classified as having TRD. Data on the covariates of sex, age, history of depression, self-harm, substance use disorders, and other psychiatric and somatic comorbidities was also used. Relative risks comparing TRD patients with other depressed patients were calculated as hazard ratios (HR) for all-cause mortality and for external and non-external causes of death, as well as excess mortality rate ratios (EMRR), with 95% confidence intervals (CI).
In total 15,013 patients (13%) were classified with TRD. Adjusted HR for all-cause mortality was 1.35 (95% CI 1.21-1.50). Mortality from external causes (including suicides and accidents) was markedly higher in TRD patients than in other depressed patients (HR 1.97; 1.69-2.29), while mortality from non-external causes was similar. The adjusted EMRR was 1.52 (1.31-1.76), highest among patients 18-29 years old (EMRR 2.03; 1.31-1.76) and patients without somatic comorbidity (EMRR 1.99; 1.63-2.43).
Severity of depression and adherence to treatment were not available in the data.
Patients with TRD may have an increased all-cause mortality compared to other depressed patients, mainly for external causes of death. The relative mortality is highest among young and physically healthy patients.
治疗抵抗性抑郁症(TRD)对死亡率的影响尚未确定。
使用瑞典国家登记处,确定了 118774 名年龄在 18-69 岁之间、曾被处方抗抑郁药并在专科护理中被诊断为抑郁症的患者。在同一抑郁发作期间至少接受过两次额外治疗试验的患者被归类为 TRD。还使用了性别、年龄、抑郁症病史、自残、物质使用障碍以及其他精神和躯体合并症的协变量数据。使用全因死亡率和外部及非外部死因的危害比(HR)以及超额死亡率比(EMRR)计算 TRD 患者与其他抑郁患者的相对风险,置信区间(CI)为 95%。
共有 15013 名患者(13%)被归类为 TRD。全因死亡率的调整 HR 为 1.35(95%CI 1.21-1.50)。TRD 患者的外部原因(包括自杀和意外事故)死亡率明显高于其他抑郁患者(HR 1.97;1.69-2.29),而非外部原因死亡率相似。调整后的 EMRR 为 1.52(1.31-1.76),18-29 岁患者最高(EMRR 2.03;1.31-1.76),无躯体合并症患者最高(EMRR 1.99;1.63-2.43)。
数据中未提供抑郁症的严重程度和治疗依从性。
与其他抑郁患者相比,TRD 患者的全因死亡率可能增加,主要是由于外部原因死亡。相对死亡率在年轻和身体健康的患者中最高。